ISRCTN15718519
Active, not recruiting
未知
Supporting uptake of risk-reducing medications and minimising treatment discontinuation: a process evaluation
Peter MacCallum Cancer Centre0 sites250 target enrollmentMay 2, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Prevention of breast cancer in clients at increased risk
- Sponsor
- Peter MacCallum Cancer Centre
- Enrollment
- 250
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Eligibility Criteria for clients:
- •1\. Female.
- •2\. Age between 20 and 70 years old
- •3\. Residual lifetime breast cancer risk of at least 20% or a 10\-year risk of at least 5%, or history of lobular carcinoma in situ (LCIS) or atypical hyperplasia, or previous thoracic irradiation
- •4\. Does not require germline genetic testing to further clarify the risk
- •5\. Does not carry a pathogenic variant in a high\-risk breast cancer predisposition gene and is not an untested 1st\-degree relative for carriers
- •6\. No history of invasive breast cancer or ductal carcinoma in situ (DCIS)
- •7\. No history of bilateral mastectomy
- •8\. No prior or current use of breast cancer prevention medications
- •Eligibility for clinicians:
Exclusion Criteria
- •Not meeting the inclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Medication adherence and management of risk factors for secondary stroke preventioHealth Condition 1: I63- Cerebral infarctionCTRI/2022/06/042980World Stroke Organization
Completed
Not Applicable
Reduction of potentially inappropriate medication in the elderypotentially inappropriate medication in the elderly (no specific disease or condition necessary for study inclucion)DRKS00003610Ruhr-Universität Bochum1,275
Completed
Not Applicable
Interprofessional, risk-adjusted medication management in elderly cancer patientsMalignant diseasesElderly patients over 70 yearsC00-C97Malignant neoplasmsDRKS00021278Pharmazeutisches Institut101
Recruiting
Not Applicable
Prevention of Medication Overuse (MO) and Medication Overuse Headache (MOH): A randomized, controlled, parallel, multicenter, prospective trial using a mobile application softwareG43G44.4F55.2MigraineDrug-induced headache, not elsewhere classifiedDRKS00025961niversitätsklinikum Essen in Wahrnehmung der Aufgaben der Universität Duisburg-Essen, Campus Essen, Fachbereich Medizin; Institution: Institut für Medizinische Informatik, Biometrie und Epidemiologie960
Recruiting
Not Applicable
Pharmaceutical-pharmacological interventions to improve drug therapy safety of inpatient carelow adherence, problems with drug application/use, patients' concerns regarding their drug therapyDRKS00026088Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik100